Evidence map›Paper›PMID 29848510›Full record

ArticleClinical science (London, England : 1979)2018

Prorenin independently causes hypertension and renal and cardiac fibrosis in cyp1a1-prorenin transgenic rats.

Guangyu Zhou, Jie Wu, Chunyan Gu, Bin Wang, E Dale Abel, Alfred K Cheung, Yufeng Huang

Open access · bronzeAbstract read
In one paragraph

Article in Clinical science (London, England : 1979), 2018. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Cited by 11 papers.

0numbers the graph read from it
0cells of the map it votes in
11citing papers in PubMed
1.5field-weighted citation impact, top 16% of its field
1 · What the graph read from it

What it found

Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.

The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.

2 · The registry

The trial behind it

Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.

Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.

3 · Its place in the literature

Who cites it

11 citing papers in PubMed, 20 citations in OpenAlex.

  1. Review
  2. Article
  3. Article
  4. Review
  5. Article
  6. Article
  7. Key role for EphB2 receptor in kidney fibrosis.Clinical science (London, England : 1979) · 2021
    Article
  8. Yes-Associated Protein is Involved in Myocardial Fibrosis in Rats with Diabetic Cardiomyopathy.Diabetes, metabolic syndrome and obesity : targets and therapy · 2021
    Article
  9. Article
  10. Targeting the renin-angiotensin-aldosterone system in fibrosis.Matrix biology : journal of the International Society for Matrix Biology · 2020
    Review
  11. Article
4 · The record

Corrections and comments

PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.

5 · Who and what money

Authors and funding

7 authors at 2 institutions in 1 country.

Guangyu ZhouDivision of Nephrology, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT 84112, U.S.A.
Jie WuDivision of Nephrology, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT 84112, U.S.A.
Chunyan GuDivision of Nephrology, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT 84112, U.S.A.
Bin WangDivision of Nephrology, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT 84112, U.S.A.
E Dale AbelDivision of Endocrinology, Metabolism and Diabetes, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT 84112, U.S.A.
Alfred K CheungDivision of Nephrology, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT 84112, U.S.A.
Yufeng HuangDivision of Nephrology, Department of Internal Medicine, University of Utah Health, Salt Lake City, UT 84112, U.S.A. yufeng.huang@hsc.utah.edu.
China Medical University · CNNantong University · CN

Funding

Receptor-mediated actions of renin in kidney fibrosisK01DK077955 · NIDDK · UNIVERSITY OF UTAH · PI HUANG, YUFENG · 2008 to 2012
$653k
NIDDK NIH HHS K01 DK077955
6 · The paper itself

Abstract

Plasma prorenin is commonly elevated in diabetic patients and appears to predict the development of diabetic nephropathy. However, the pathological role of prorenin is unclear. In the present study, a transgenic, inducible, hepatic prorenin-overexpressing rat model was generated and the effect of prorenin in organ injury was examined. Four groups of rats (cyp1a1 prorenin transgenic male and female rats and non-transgenic littermates) were assigned to receive a diet containing 0.3% of the transgene inducer indole-3-carbinol (I3C) for 4 weeks. Plasma prorenin concentration was increased and mean arterial pressure (MAP) increased from 80 ± 18 to 138 ± 17 (mmHg), whereas renal prorenin/renin protein expression was unchanged, in transgenic rats fed with I3C diet. The intact prorenin, not renin, in plasma and urine samples was further observed by Western blot analysis. Importantly, transgenic rats with high levels of prorenin developed albuminuria, glomerular and tubulointerstitial fibrosis associated with increased expression of transforming growth factor β (TGFβ) 1 (TGFβ1), plasminogen activator inhibitor-1 (PAI-1), collagen, and fibronectin (FN). These rats also exhibited cardiac hypertrophy determined by echocardiography, with elevated ratio of heart weight to body weight (HW/BW). Cardiac collagen in interstitial and perivascular regions was prominent, accompanied by the increase in mRNA contents of atrial natriuretic peptide (ANP), brain natriuretic peptide (BNP), β-myosin heavy chain (β-MHC), TGFβ1, PAI-1, and collagen in the heart tissue. Furthermore, renal protein levels of p-NF-κB-p65 and monocyte chemoattractant protein-1 (MCP-1), NAPDH oxidases, malondialdehyde (MDA) and 8-isoprostane (8-IP), p-ERK, p-β-catenin, and p-Akt were dramatically increased in prorenin overexpressing rats. These results indicate that prorenin, without being converted into renin, causes hypertension, renal and cardiac fibrosis via the induction of inflammation, oxidative stress and the ERK, β-catenin, and Akt-mediated signals.

Indexed as

AlbuminuriaAnimalsCardiomegalyEchocardiographyFemaleFibrosisGene ExpressionHypertensionKidneyMaleMyocardiumOrgan SizeOxidative StressRats, TransgenicReninSignal TransductionRenincardiac diseasehypertensionProreninrenal diseaserenin

Identifiers

PMID29848510
PMCPMC6024026
OpenAlexW2806772548

What OpenQuestion holds

Textmetadata
LicenceCC BY-NC-ND
Read underepoch 390

Registered trials

None linked

Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.